Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Humana logoHumana HUM

Humana said George Renaudin, Insurance Segment President, will retire by Q3 2026 following a 29-year career at the company. The company explained that Renaudin has agreed to serve in an advisory capacity after his transition date on December 16, 2025.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Period of report Summary published (UTC)

Key points

AI summary
  1. Humana said George Renaudin, Insurance Segment President, will retire by Q3 2026 following a 29-year career at the company. The company explained that Renaudin has agreed to serve in an advisory capacity after his transition date on December 16, 2025.

  2. Humana said Renaudin will provide strategic advisory services until December 31, 2026 after his transition date, and thereafter transition to the company's variable staffing pool (temporary worker status) until March 1, 2027. During the VSP period, he will not receive a salary but will be paid an hourly rate for work performed.

  3. Humana said Aaron Martin will join the company in January 2026 as President of Medicare Advantage and will assume the role of Insurance Segment President following Renaudin's transition date. John Barger, currently President of Medicaid and Dual Eligible programs, will be promoted to President of Medicare Advantage.

  4. Humana reaffirmed its guidance of approximately $12.26 in diluted earnings per common share (GAAP) or approximately $17.00 in adjusted earnings per common share (Adjusted EPS) for 2025. The company said this guidance is consistent with the guidance issued in its press release dated November 5, 2025 and Form 8-K filed on December 1.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Insurance Segment President Retirement Announced

Humana said George Renaudin, Insurance Segment President, will retire by Q3 2026 following a 29-year career at the company. The company explained that Renaudin has agreed to serve in an advisory capacity after his transition date on December 16, 2025.

Source · Based on the filing body and exhibits

Renaudin Advisory and VSP Period Agreement Terms

Humana said Renaudin will provide strategic advisory services until December 31, 2026 after his transition date, and thereafter transition to the company's variable staffing pool (temporary worker status) until March 1, 2027. During the VSP period, he will not receive a salary but will be paid an hourly rate for work performed.

Source · Based on the filing body and exhibits

Aaron Martin Hired; Succession Plan Announced

Humana said Aaron Martin will join the company in January 2026 as President of Medicare Advantage and will assume the role of Insurance Segment President following Renaudin's transition date. John Barger, currently President of Medicaid and Dual Eligible programs, will be promoted to President of Medicare Advantage.

Source · Based on the filing body and exhibits

2025 Annual EPS Guidance Reaffirmed

Humana reaffirmed its guidance of approximately $12.26 in diluted earnings per common share (GAAP) or approximately $17.00 in adjusted earnings per common share (Adjusted EPS) for 2025. The company said this guidance is consistent with the guidance issued in its press release dated November 5, 2025 and Form 8-K filed on December 1.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.